APN:JSE
Aspen Pharmacare Holdings Ltd
ZACÂ 15,826.00
arrow_downward
-0.28%(-45.00) 1D
Oct 9, 5:00:00 PM GMT+2 · ZAC
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for APN...
Open
ZACÂ 15,623.00
High
ZACÂ 15,915.00
Low
ZACÂ 15,623.00
Mkt. cap
68.51B
Avg. vol.
1.78M
Volume
902.71K
Dividend
1.47%
Quarterly dividend
ZACÂ 58.00
Ex-dividend date
Oct 7, 2026
52-wk high
ZACÂ 16,621.00
52-wk low
ZACÂ 9,070.00
EPS
-ZACÂ 2.00
Shares outstanding
432.92M
No. of employees
9K
Open
ZACÂ 15,623.00
High
ZACÂ 15,915.00
Low
ZACÂ 15,623.00
Mkt. cap
68.51B
Avg. vol.
1.78M
Volume
902.71K
Dividend
1.47%
Quarterly dividend
ZACÂ 58.00
Ex-dividend date
Oct 7, 2026
52-wk high
ZACÂ 16,621.00
52-wk low
ZACÂ 9,070.00
EPS
-ZACÂ 2.00
Shares outstanding
432.92M
No. of employees
9K
News stories
From web sources and news partners
36Kr
·
8 minutes ago
Can the US Stock Bull Market Still Continue? 2025 Outlook, Key Drivers & Future Trend Analysis
marketscreener.com
·
7 minutes ago
Gold hits one-week high, heads for weekly gain on bargain-hunting
bloomingbit
·
22 minutes ago
Bloomberg Analyst Balchunas Says Fears Over Narrow S&P 500 Gains Are Overdone
ChartMill
·
1 hour ago
These S&P500 stocks are gapping in today's session
Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. The largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016, Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for five years in the European Union. Wikipedia
About Aspen Pharmacare Holdings Ltd
CEOStephen Saad
Employees9.34K
Founded1850
HeadquartersDurban, KwaZulu-Natal, South Africa
SectorPharmaceutical industry
Websiteaspenpharma.com